ClassID:

20135

A61K9/4808 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Recent Application in this class:
#1
20260151341
2026-06-04

NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS

#2
20260124252
2026-05-07

Dietary Pattern Directed Nutritional Supplementation Composition and Methods for Attenuating Age-Related Cognitive Decline or Enhancing Cognitive Function

#3
20260115142
2026-04-30

PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND ACETYLSALICYLIC ACID, PROCESS FOR PREPARING THE SAME, AND USES THEREOF

#4
20260108543
2026-04-23

Self-Emulsifying Systems For Cannabinoids

#5
20260102370
2026-04-16

METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS

#6
20260097071
2026-04-09

METHOD OF TREATING AN ACUTE OR CHRONIC RESPIRATORY DISEASE IN A MAMMALIAN SUBJECT

#7
20260096996
2026-04-09

PHARMACEUTICAL COMPOSITIONS OF TRETINOIN AND METHODS OF PRODUCING SUCH COMPOSITIONS

#8
20260083767
2026-03-26

SOLID DOSAGE FORM OF A SMALL MOLECULE ANTIVIRAL AND USES THEREOF

#9
20260076950
2026-03-19

USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME

#10
20260076913
2026-03-19

STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF

#11
20260069629
2026-03-12

RECEPTACLE, DEVICE FOR RELEASING CARBON MONOXIDE, TREATMENT SYSTEM, SET FOR TREATING LIVING CELLS, METHOD OF TREATING A MAMMAL, AND CARBON MONOXIDE

#12
20260069546
2026-03-12

LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF

#13
20260053749
2026-02-26

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#14
20260027063
2026-01-29

Compositions for Treatment of Attention Deficit Hyperactivity Disorder

#15
20260014083
2026-01-15

Orally Administrable Pharmaceutical Dosage Form Comprising Lanthanum and Its Use in a Method Of Treatment of Hyperoxaluria

#16
20260007627
2026-01-08

METHODS OF TREATING MULTIPLE SCLEROSIS

#17
20260007608
2026-01-08

NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION

#18
20260007607
2026-01-08

NON-DIGESTIBLE CAPSULES FOR THE DELIVERY OF FLUID ABSORBING MATERIALS

#19
20260000697
2026-01-01

COMBINATION FORMULATION OF CEDAZURIDINE

#20
20250387453
2025-12-25

Methods and Compositions for Treating Diabetes

#21
20250387449
2025-12-25

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

#22
20250381178
2025-12-18

TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT

#23
20250375385
2025-12-11

CAPSULE FORMULATIONS

#24
20250375384
2025-12-11

SOFT DUAL CHAMBERED LIQUID-GEL CAPSULE AND METHOD TO DELIVER SUBLINGUAL AND INGESTIBLE CANNABIS COMPOSITIONS

#25
20250375383
2025-12-11

Structured solid dosage form

#26
20250367295
2025-12-04

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

#27
20250367271
2025-12-04

COMPOSITIONS FOR TREATING ADDICTION

#28
20250367123
2025-12-04

PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA

#29
20250345279
2025-11-13

COVALENTLY CROSSLINKED POLYSACCHARIDES AND METHODS OF USE THEREOF

#30
20250332149
2025-10-30

PIPERIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS

#31
20250325518
2025-10-23

USE OF A COMBINATION OF SACUBITRIL AND VALSARTAN

#32
20250319050
2025-10-16

PHARMACEUTICAL FORMULATION

#33
20250319033
2025-10-16

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#34
20250302872
2025-10-02

COMPOSITIONS FOR INHIBITING ANAEROBIC MICROORGANISMS

#35
20250295598
2025-09-25

MULTICOMPONENT CAPSULES

#36
20250288580
2025-09-18

TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT

#37
20250288527
2025-09-18

DEVICES AND METHODS TO IMPROVE BIOAVAILABILITY OF THERAPEUTIC AGENTS

#38
20250282721
2025-09-11

DRUG DELIVERY SYSTEM COMPRISING MONOMETHYL FUMARATE

#39
20250268922
2025-08-28

PHARMACEUTICAL COMPOSITION COMPRISING ACETYLSALICYLIC ACID AND PROTON PUMP INHIBITOR

#40
20250268834
2025-08-28

IONIC LIQUID SALTS OF ACTIVE PHARMACEUTICAL INGREDIENTS

#41
20250268524
2025-08-28

Degradable device for the passive and traceable release of a substance

#42
20250262196
2025-08-21

PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF

#43
20250255887
2025-08-14

DIETARY NUTRIENT COMPOSITIONS

#44
20250255836
2025-08-14

PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD

#45
20250255819
2025-08-14

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

#46
20250249018
2025-08-07

IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS INCLUDING BUPROPION FOR WEIGHT LOSS

#47
20250249017
2025-08-07

IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS INCLUDING NALTREXONE FOR WEIGHT LOSS

#48
20250249016
2025-08-07

IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS

#49
20250248943
2025-08-07

SUSTAINED RELEASE COMPOSITION COMPRISING A METHYLCELLULOSE

#50
20250236665
2025-07-24

USTEKINUMAB DOSAGE FORMS AND METHODS

#51
20250235408
2025-07-24

NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION

#52
20250213554
2025-07-03

PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS

#53
20250213492
2025-07-03

HARD CAPSULE INCLUDING MULTIPLE LOCKING PARTS

#54
20250205181
2025-06-26

ANANDAMIDE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES

#55
20250186522
2025-06-12

COMPOSITIONS AND METHODS FOR PROMOTING A HEALTHY MICROBIAL FLORA IN A MAMMAL

#56
20250177290
2025-06-05

DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF

#57
20250161165
2025-05-22

DIE ROLL FOR FORMING SOFT GEL CAPSULES

#58
20250152534
2025-05-15

METHOD OF TREATMENT OF PARKINSON’S DISEASE

#59
20250152517
2025-05-15

PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES

#60
20250152481
2025-05-15

COMPOSITION CONTAINING LIPOSOMES AND BIOSURFACTANTS

#61
20250135107
2025-05-01

DEVICE, SYSTEM AND METHODS FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS

#62
20250134818
2025-05-01

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#63
20250099389
2025-03-27

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#64
20250090534
2025-03-20

Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof

#65
20250082914
2025-03-13

SWALLOWABLE, SELF-EXPANDABLE DRUG DELIVERY DEVICE AND USES THEREOF

#66
20250082828
2025-03-13

MEDICAL DEVICES AND IMPLEMENTS WITH LIQUID-IMPREGNATED SURFACES

#67
20250082673
2025-03-13

COLON LAVAGE SYSTEM

#68
20250073301
2025-03-06

Delayed Release Compositions of Linaclotide

#69
20250064748
2025-02-27

DRUG DELIVERY VEHICLES, METHODS OF PRODUCING DRUG DELIVERY VEHICLES, AND METHODS OF USING DRUG DELIVERY VEHICLES

#70
20250057800
2025-02-20

DRUG DELIVERY SYSTEM COMPRISING MONOMETHYL FUMARATE

#71
20250057772
2025-02-20

ORAL DOSAGE FORM WITH IONICALLY CHARGEABLE HYDROGEL FOR DELIVERY OF ACTIVE AGENT

#72
20250057770
2025-02-20

Monomethylfumarate Prodrug Compositions

#73
20250049753
2025-02-13

METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS

#74
20250049724
2025-02-13

MICROCAPSULE DISPERSIONS WITH EMULSIFIER

#75
20250032421
2025-01-30

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#76
20250025413
2025-01-23

Preparation Method for Nutritional Gummies Containing High-loading Liquid Capsules

#77
20250019354
2025-01-16

Crystal Modifications of Odevixibat

#78
20250017988
2025-01-16

Probiotic Delivery Systems

#79
20240424268
2024-12-26

SWALLOWABLE DRUG DELIVERY DEVICE AND METHODS OF DRUG DELIVERY

#80
20240415881
2024-12-19

Compositions for inhibiting anaerobic microorganisms

#81
20240415853
2024-12-19

Cannabinoid Self-Emulsifying Systems

#82
20240415777
2024-12-19

INSTANT RELEASE PHARMACEUTICAL PREPARATION OF ANTICOAGULANT AND PREPARATION METHOD THEREFOR

#83
20240408023
2024-12-12

DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES

#84
20240408021
2024-12-12

PHARMACEUTICAL FORMULATION

#85
20240399125
2024-12-05

OPIOID OVERDOSE RESCUE DEVICE

#86
20240398714
2024-12-05

STABLE CAPSULES WITH FECAL MICROBIOTA OR A CULTURE OF MICROORGANISMS

#87
20240398713
2024-12-05

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#88
20240390339
2024-11-28

USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME

#89
20240390267
2024-11-28

DRUG DELIVERY DEVICE WITH CAPSULE LOCK

#90
20240374661
2024-11-14

LACTOBACILLUS PLANTARUM ZUST49 AND BACTERIAL AGENT, AND USE THEREOF

#91
20240374526
2024-11-14

TARGETED GASTROINTESTINAL TRACT DELIVERY OF PROBIOTIC ORGANISMS AND/OR THERAPEUTIC AGENTS

#92
20240366636
2024-11-07

ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS

#93
20240366591
2024-11-07

Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

#94
20240358650
2024-10-31

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

#95
20240358646
2024-10-31

HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING

#96
20240358630
2024-10-31

MICROMOTORS AND NANOMOTORS FOR GASTROINTESTINAL DIAGNOSIS AND TREATMENT APPLICATIONS

#97
20240350417
2024-10-24

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#98
20240342100
2024-10-17

Orally Ingestible Delivery System

#99
20240342099
2024-10-17

INGESTIBLE DEVICE

#100
20240342098
2024-10-17

INGESTIBLE DEVICES, SYSTEMS, AND METHODS THEREOF FOR GASTROINTESTINAL APPLICATIONS

#101
20240325313
2024-10-03

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI

#102
20240325312
2024-10-03

Composition comprising cannabidiol and hydroxychloroquine in a fixed dose combination capsule

#103
20240316077
2024-09-26

Self-Emulsifying Systems For Cannabinoids

#104
20240315975
2024-09-26

SOLID SELF-EMULSIFYING PHARMACEUTICAL COMPOSITIONS

#105
20240307455
2024-09-19

COMPOSITIONS, DEVICES AND METHODS FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES

#106
20240307315
2024-09-19

DUAL RELEASE DOSAGE FORM CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR MAKING SAME

#107
20240299503
2024-09-12

Methods and Compositions for Treating Diabetes

#108
20240299470
2024-09-12

METHODS OF PROBIOTIC TREATMENT TO IMPROVE HUMAN HEALTH

#109
20240299343
2024-09-12

METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS

#110
20240299306
2024-09-12

CAPSULE FORMULATIONS

#111
20240293329
2024-09-05

PHARMACEUTICALLY STABLE SOFT CAPSULE COMPRISING TWO OR MORE DIFFERENT COMPOSITIONS

#112
20240285699
2024-08-29

Method to Control Administration of Active Substance to the Digestive Tract

#113
20240285649
2024-08-29

PROGESTOGEN FORMULATIONS FOR USE IN MODULATING A CYTOKINE STORM MEDIATOR

#114
20240277986
2024-08-22

INGESTIBLE DEVICE FOR DELIVERY OF THERAPEUTIC AGENT TO THE GASTROINTESTINAL TRACT

#115
20240277679
2024-08-22

Pharmaceutical Formulations Containing Relacorilant, a Heteroaryl-Ketone Fused Azadecalin Compound

#116
20240277670
2024-08-22

SAFE USE OF MMP-12 INHIBITOR

#117
20240269247
2024-08-15

Microbiome protection from oral antibiotics

#118
20240269081
2024-08-15

NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION

#119
20240261408
2024-08-08

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

#120
20240245685
2024-07-25

PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF

#121
20240226023
2024-07-11

Compositions for Treatment of Attention Deficit Hyperactivity Disorder

#122
20240226021
2024-07-11

DRUG DELIVERY IN NEGATIVE POISSON`S RATIO STRUCTURES

#123
20240216322
2024-07-04

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE

#124
20240216318
2024-07-04

TWO-COMPONENT COMPOSITION

#125
20240207290
2024-06-27

CYCLIC PHOSPHONATE COMPOSITION AND PREPARATION METHOD THEREOF

#126
20240207227
2024-06-27

USE OF A COMBINATION OF SACUBITRIL AND VALSARTAN

#127
20240197639
2024-06-20

CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR

#128
20240189458
2024-06-13

METHODS FOR IN VIVO DELIVERY OF MICROBES TO HUMAN MICROENVIRONMENTS

#129
20240189224
2024-06-13

IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE

#130
20240180991
2024-06-06

INDIVIDUAL DOSING OF CANNABIS AND TOBACCO FOR STANDARDIZATION AND CONTROL

#131
20240156738
2024-05-16

Pharmaceutical composition and administrations thereof

#132
20240139308
2024-05-02

TRANSDERMAL VACCINE

#133
20240131085
2024-04-25

LONG-TERM STABLE LIVE FECAL MICROBIOTA COMPOSITION

#134
20240130977
2024-04-25

Orally available articles containing at least one stabilized supplement therein

#135
20240130975
2024-04-25

DRUG DELIVERY IN NEGATIVE POISSON`S RATIO STRUCTURES

#136
20240122920
2024-04-18

PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS

#137
20240122862
2024-04-18

MEMBRANE-BASED TWO COMPONENT THERAPEUTIC GAS RELEASE SYSTEM FOR ORAL ADMINISTRATION

#138
20240122808
2024-04-18

COAXIAL NOZZLE CONFIGURATION AND METHODS THEREOF

#139
20240115656
2024-04-11

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#140
20240115499
2024-04-11

DHA and Choline Emulsion

#141
20240109959
2024-04-04

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#142
20240108694
2024-04-04

METHOD OF DELIVERING A SOMATOSTATIN COMPOUND INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#143
20240108047
2024-04-04

PROBIOTIC MICROCAPSULE AND PREPARATION METHOD THEREOF

#144
20240099971
2024-03-28

Self-emulsifying cannabidiol formulations

#145
20240092748
2024-03-21

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

#146
20240091304
2024-03-21

FORMULATIONS COMPRISING CYCLOSPORIN A

#147
20240082488
2024-03-14

Device, system and methods for the oral delivery of therapeutic compounds

#148
20240082265
2024-03-14

SUSTAINED RELEASE FORMULATIONS OF CRYSTALLINE DRUGS

#149
20240082165
2024-03-14

METHODS AND COMPOSITIONS FOR PRECISION RELEASE OF PROBIOTICS TO IMPROVE HUMAN HEALTH

#150
20240075094
2024-03-07

Low-Dose Stable Formulations of Linaclotide

#151
20240075043
2024-03-07

Immediate and controlled release appetite suppressant compositions for weight loss

#152
20240074979
2024-03-07

FABRICATION OF TEXTILE-BASED CAPSULES

#153
20240066041
2024-02-29

MICROPARTICLES CONTAINING STABILIZED CBD OIL, AND METHODS FOR THE PRODUCTION THEREOF

#154
20240058480
2024-02-22

CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT

#155
20240050721
2024-02-15

TREATMENTS FOR HEMOPHILIA A

#156
20240041780
2024-02-08

SEALING FLUID FOR SEALING CAPSULES

#157
20240041777
2024-02-08

PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS

#158
20240024382
2024-01-25

Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

#159
20240024250
2024-01-25

SELF-ACTUATING ARTICLES

#160
20240024249
2024-01-25

ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A METHYL HYDROGEN FUMARATE PRODRUG

#161
20240017048
2024-01-18

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#162
20240016985
2024-01-18

Medical devices and implements with liquid-impregnated surfaces

#163
20240016762
2024-01-18

DUAL ANALGESIC/ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CB2 RECEPTOR AGONISTS, COMBINATIONS, AND METHODS OF USE THEREOF

#164
20240016739
2024-01-18

NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS

#165
20240010618
2024-01-11

PROCESS FOR THE PREPARATION OF BRIVARACETAM

#166
20240009136
2024-01-11

SYSTEM, METHOD, DEVICE, AND COMPOUND FOR FACILITATING MULTICOMPARTMENT CAPSULES

#167
20240001094
2024-01-04

PREPARATION COMPRISING EXANATIDE FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT

#168
20230405053
2023-12-21

ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS

#169
20230398173
2023-12-14

Delayed Release Compositions of Linaclotide

#170
20230398066
2023-12-14

DRUG DOSAGE FORMS FOR STOMACH RETENTION

#171
20230390193
2023-12-07

GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM

#172
20230381268
2023-11-30

Granular Pharmaceutical Composition

#173
20230381265
2023-11-30

OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS

#174
20230381203
2023-11-30

Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and use

#175
20230372237
2023-11-23

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#176
20230364159
2023-11-16

MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE

#177
20230364022
2023-11-16

Delayed release composition for peroral administration

#178
20230355689
2023-11-09

SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL EXTRACELLULAR VESICLES

#179
20230355533
2023-11-09

BIODEGRADABLE POLYCAPROLACTONE CAPSULE FOR ANTIBODY RELEASE AND DEGRADATION

#180
20230355532
2023-11-09

ORAL DRUG DELIVERY DEVICE WITH EXPANDING BAND

#181
20230338719
2023-10-26

SUBSTANCE DELIVERING CAPSULE

#182
20230338399
2023-10-26

ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS

#183
20230330176
2023-10-19

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

#184
20230321117
2023-10-12

USE OF GANAXOLONE IN TREATING AN EPILEPSY DISORDER

#185
20230310313
2023-10-05

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#186
20230301923
2023-09-28

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#187
20230301902
2023-09-28

IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE

#188
20230293621
2023-09-21

GREEN TEA FLOWER FORMULATION FOR WEIGHT MANAGEMENT

#189
20230285330
2023-09-14

Compositions and methods for treating metabolic disorders

#190
20230277484
2023-09-07

COMPOSITIONS AND METHODS TO PROMOTE BRAIN HEALTH

#191
20230277468
2023-09-07

TARGETED GASTROINTESTINAL TRACT DELIVERY OF PROBIOTIC ORGANISMS AND/OR THERAPEUTIC AGENTS

#192
20230270830
2023-08-31

Microbiome protection from oral antibiotics

#193
20230270777
2023-08-31

Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy

#194
20230263854
2023-08-24

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#195
20230263799
2023-08-24

Compositions and methods for treating centrally mediated nausea and vomiting

#196
20230240996
2023-08-03

Oral Medicine Delivery Capsule

#197
20230233821
2023-07-27

INGESTIBLE DEVICE HAVING A SPIKE ASSEMBLY

#198
20230233679
2023-07-27

COMPOSITIONS, DEVICES AND METHODS FOR INDUCING IMMUNE RESPONSES TO INFECTIOUS AGENTS

#199
20230227456
2023-07-20

ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMOD

#200
20230227455
2023-07-20

METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD

#201
20230226063
2023-07-20

PHARMACEUTICAL FORMULATION OF PALBOCICLIB AND A PREPARATION METHOD THEREOF

#202
20230225981
2023-07-20

LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF

#203
20230218535
2023-07-13

Self-righting systems, methods, and related components

#204
20230218518
2023-07-13

Compositions and methods for treating eosinophilic disorders

#205
20230210956
2023-07-06

METHODS AND COMPOSITIONS FOR TREATING DIABETES

#206
20230210781
2023-07-06

CONTROLLED RELEASE OF SELF-EMBEDDING PARTICLES FOR LOCALIZED DRUG DELIVERY

#207
20230203148
2023-06-29

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#208
20230190831
2023-06-22

SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES

#209
20230190795
2023-06-22

Methods for inhibiting anaerobic microorganisms

#210
20230190794
2023-06-22

Compositions for inhibiting anaerobic microorganisms

#211
20230165789
2023-06-01

IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE

#212
20230149372
2023-05-18

Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome

#213
20230149365
2023-05-18

DOSAGE FORMS OF TAFAMIDIS AND ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#214
20230149315
2023-05-18

Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

#215
20230142270
2023-05-11

Delayed Release Compositions of Linaclotide

#216
20230141842
2023-05-11

Compounds to Modulate Intestinal Absorption of Nutrients

#217
20230124923
2023-04-20

Instant release pharmaceutical preparation of anticoagulant and preparation method therefor

#218
20230119567
2023-04-20

PHARMACEUTICAL FORMULATION

#219
20230115025
2023-04-13

GASTRO-RETENTIVE DRUG DELIVERY SYSTEM

#220
20230114627
2023-04-13

COMPOSITION COMPRISING A METAL ASCORBO-CAMPHORATE COMPOUND AND METHOD FOR PREVENTION AND/OR TREATMENT OF PAPILLOMAVIRUS INFECTIONS

#221
20230114360
2023-04-13

Sublingual Delivery for Mitigation of Side Effects Associated with Zicronapine

#222
20230113303
2023-04-13

Granular Pharmaceutical Composition

#223
20230106844
2023-04-06

Die roll for forming soft gel capsules

#224
20230092422
2023-03-23

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#225
20230090812
2023-03-23

Capsules with opacifier

#226
20230085008
2023-03-16

Pharmaceutical compositions of mifepristone

#227
20230078925
2023-03-16

PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA

#228
20230076766
2023-03-09

METHOD FOR TREATMENT OF ROSACEA IN PATIENTS AGED 35-64 YEARS

#229
20230076111
2023-03-09

Methods for manufacturing capsules with ingestible event markers

#230
20230075677
2023-03-09

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

#231
20230072816
2023-03-09

Method To Improve The Health Of The Microbiome In A Human Gastrointestinal System And Multi-Chamber Probiotic Delivery Products Therefor

#232
20230062872
2023-03-02

Pharmaceutical formulation

#233
20230057086
2023-02-23

PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND BACTERIOPHAGE APPLICATION DEVICE

#234
20230051463
2023-02-16

Methotrexate Dosage Form

#235
20230051314
2023-02-16

BIODEGRADABLE MICROCAPSULES

#236
20230050912
2023-02-16

Self-righting systems and related components and methods

#237
20230038074
2023-02-09

MAGNETIC MINIATURE DEVICE AND SYSTEM FOR REMOTELY MANEUVERING IT

#238
20230036151
2023-02-02

ANTI-METHANOGENIC COMPOSITIONS AND USES THEREOF

#239
20230034761
2023-02-02

INGESTIBLE DEVICE WITH PHARMACEUTICAL PRODUCT

#240
20230032377
2023-02-02

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound

#241
20230022463
2023-01-26

IMPLANTABLE MEDICAL DEVICES FOR EXTENDED RELEASE OF THERAPEUTIC AGENTS

#242
20230017712
2023-01-19

SUSTAINED RELEASE DRUG DELIVERY DEVICE

#243
20230017603
2023-01-19

Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

#244
20230014170
2023-01-19

INGESTIBLE MEDICAL DELIVERY DEVICES

#245
20230000775
2023-01-05

SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE

#246
20230000764
2023-01-05

PRESSURIZED NUTRITIONAL SUPPLEMENT DELIVERY

#247
20220409557
2022-12-29

PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD

#248
20220401450
2022-12-22

PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER

#249
20220401371
2022-12-22

Compartmented hard shell capsule and apparatus and method for forming, filling, and encapsulating a compartmented hard shell capsule

#250
20220395505
2022-12-15

Pharmaceutical Composition Comprising Quinazoline Derivative or Salt Thereof

#251
20220378815
2022-12-01

Method for treating coronavirus infections

#252
20220378706
2022-12-01

PHARMACEUTICAL COMPOSITION COMPRISING PDE9 INHIBITOR

#253
20220370392
2022-11-24

Method and Composition for Increasing Muscle Protein Synthesis

#254
20220362195
2022-11-17

DIMETHYL FUMARATE PARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#255
20220362188
2022-11-17

Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans

#256
20220339231
2022-10-27

Sustained Release Formulation Containing Aspalathus linearis Extract

#257
20220339113
2022-10-27

Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates

#258
20220339112
2022-10-27

TARGETED CHEMICAL DELIVERY CAPSULE

#259
20220339095
2022-10-27

METHODS FOR DELIVERING ETANERCEPT PREPARATIONS INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#260
20220331281
2022-10-20

PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

#261
20220323733
2022-10-13

Swallowable drug delivery device and methods of drug delivery

#262
20220323393
2022-10-13

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE

#263
20220305033
2022-09-29

Dietary nutrient compositions

#264
20220296662
2022-09-22

Compositions and methods for promoting a healthy microbial flora in a mammal

#265
20220288111
2022-09-15

Pharmaceutical compositions for delivery of peptide

#266
20220288068
2022-09-15

PHARMACEUTICAL PREPARATION

#267
20220281832
2022-09-08

Crystal modifications of odevixibat

#268
20220280435
2022-09-08

Components with high API loading

#269
20220280433
2022-09-08

STABLE LOW DIGESTIVE ENZYME CONTENT FORMULATION

#270
20220265560
2022-08-25

CAPSULE DEVICE HAVING IMPROVED SELF-RIGHTING ABILITY

#271
20220257855
2022-08-18

Self-actuating articles

#272
20220257696
2022-08-18

Granular Pharmaceutical Composition

#273
20220257520
2022-08-18

MONOMETHYLFUMARATE PRODRUG COMPOSITIONS

#274
20220249520
2022-08-11

COMPOSITION FOR TREATING OR PREVENTING MILD COGNITIVE IMPAIRMENT

#275
20220249505
2022-08-11

Appetite suppressant compositions and methods thereof

#276
20220241206
2022-08-04

Pharmaceutical composition and administrations thereof

#277
20220233453
2022-07-28

Capsule formulations

#278
20220233452
2022-07-28

MINI SOFTGEL NAPROXEN COMPOSITION

#279
20220226352
2022-07-21

DIETARY NUTRIENT COMPOSITIONS

#280
20220218724
2022-07-14

Two-component composition

#281
20220218649
2022-07-14

COMPOSITION FOR TREATING OPIOID WITHDRAWAL AND METHOD OF MANUFACTURE

#282
20220218618
2022-07-14

DOSING SYSTEM FOR CONTROLLED SUBSTANCES RELEASE BY MEANS OF DOSING MEMBRANES

#283
20220211641
2022-07-07

COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE

#284
20220211629
2022-07-07

CANNABINOID FORMULATIONS

#285
20220202729
2022-06-30

Delayed release composition for peroral administration

#286
20220202726
2022-06-30

Dry powder composition for peroral administration

#287
20220202713
2022-06-30

Curcumin Solubilisate

#288
20220202707
2022-06-30

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#289
20220193057
2022-06-23

Formulations of pimavanserin

#290
20220175890
2022-06-09

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#291
20220175681
2022-06-09

SELF-RIGHTING ARTICLES

#292
20220168226
2022-06-02

SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH METFORMIN

#293
20220160641
2022-05-26

CAPSULE WITH INTERNAL DIAPHRAGM FOR IMPROVED BIOAVAILABILITY

#294
20220152097
2022-05-19

Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy

#295
20220151965
2022-05-19

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

#296
20220151957
2022-05-19

Biguanide compositions and methods of treating metabolic disorders

#297
20220151940
2022-05-19

TISSUE ANCHORING ARTICLES

#298
20220151939
2022-05-19

PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES AND METHODS FOR PRODUCING SAME

#299
20220143107
2022-05-12

LONG-TERM STABLE LIVE FECAL MICROBIOTA COMPOSITION

#300
20220143056
2022-05-12

METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES